Advertisements

Oxipor VHC

Quick links to important sections

Oxipor VHC

Advertisements
Advertisements

Method of action: Antipsoriatic, Keratolytic

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Oxipor VHC

Property Description
Active ingredient Coal Tar
Form Topical Solution
Pharmacological class Keratoplastic Agent
Common Use Management of chronic scaling and itching
Origin Derived (from bituminous coal)

Oxipor VHC is a medicated dermatological preparation designed for topical application to the skin and scalp. This product is classified as a single-active ingredient preparation that utilizes Coal Tar as its active substance. The designation VHC confirms it is a Very Highly Concentrated formulation, indicating a specific delivery system. As an Over-the-Counter (OTC) product, it is accessible for the self-management of symptoms.

This preparation is classified as a keratoplastic agent, meaning its primary function is to normalize and moderate the growth and maturation cycle of skin cells. Coal Tar is used in dermatological formulations to target conditions characterized by rapid cell turnover. The active ingredient is intended to help stabilize the skin's renewal process.


Composition and Pharmacological Class (Keratoplastic Agent)

The active ingredient, Coal Tar, is delivered in an alcohol-based topical solution base to achieve a high concentration and facilitate penetration during external use. This formulation places Oxipor VHC within the dermatological agent class of medicines. The concentrated liquid form is designed for application to thick, chronic scale on the scalp.

As a keratoplastic agent, the preparation's pharmacological role is distinct from that of simple emollients or anti-inflammatory drugs; it involves the stabilization of the cellular growth rate, which acts to prevent the rapid, excessive build-up of skin tissue. This action supports the general management of symptoms associated with chronic skin conditions.


General Purpose and Mechanism of Symptomatic Relief

The general purpose of Oxipor VHC is to manage and relieve the common symptoms associated with chronic scalp conditions, such as scaling and itching. This is achieved through the cytostatic effect of Coal Tar, which acts to inhibit the excessive reproduction of skin cells.

By moderating the pace of cellular turnover, the preparation reduces the formation of thickened, scaling plaques and promotes the shedding of existing build-up. Furthermore, the inherent antipruritic action of the active ingredient provides the general benefit of alleviating the persistent discomfort, burning, and itching often accompanying these conditions.

Regulatory References

  1. NIH, Coal Tar for Psoriasis
Advertisements

What side effects are possible with Oxipor VHC?

Possible Side Effects and Safety Information

The official safety profile for topical Coal Tar, the active ingredient in Oxipor VHC, is primarily defined by localized dermatological reactions and specific exposure constraints as documented in regulatory sources.


Official Adverse Reactions and Frequency

Adverse effects are chiefly limited to the skin and subcutaneous tissues. The most common and expected reactions include stinging, burning sensation, and staining of the skin, hair, or clothing. Less commonly, regulatory labeling notes the potential for folliculitis (inflammation of hair follicles) and acne-like eruptions (Coal Tar Acne) with prolonged application. While rare, severe local irritation or signs of a systemic allergic reaction are defined as clinically significant adverse events that require immediate attention.


Key Safety Constraints

Constraint Category Official Safety Requirement
Photosensitivity Use of this product causes increased sensitivity to light; strict avoidance of sun and artificial UV light is required while the product remains on the skin.
Application Site The product is strictly for external use only and must not be applied to acutely inflamed, infected, irritated, or broken skin to prevent excessive irritation or absorption.
Time/Exposure Local irritation, such as stinging, is often more pronounced at the beginning of treatment.

Population-Specific Statements

Official labeling generally advises consulting a healthcare professional before use in the pediatric population (children under 12 years of age) and during pregnancy or lactation, as specific safety data for these groups may be limited in topical formulations. The resulting safety profile is structured to emphasize managing local effects and external exposure risks.

Advertisements

Overdose and Emergency Response

Oxipor VHC Overdose and When to Seek Help

Oxipor VHC is a topical medication containing coal tar and salicylic acid. The risk of overdose is primarily associated with ingestion or excessive topical use, especially over large body areas for prolonged periods or on broken skin, which can lead to increased systemic absorption.

Potential Overdose Symptoms (Salicylism)

Excessive systemic absorption of salicylic acid can lead to a condition known as salicylism. Symptoms may vary in severity and can include:

Symptom Category Potential Manifestations
Auditory/Sensory Ringing in the ears (tinnitus), dizziness, hearing loss
Gastrointestinal Nausea, vomiting, stomach upset
Neurological Confusion, delirium, hyperventilation (rapid breathing)

In severe cases, more serious complications such as metabolic changes (e.g., acidosis) or central nervous system effects may occur. Coal tar overdose symptoms are generally less common with this formulation but can include severe skin irritation or allergic reactions.

When to Seek Emergency Medical Help

Always seek immediate medical attention or call a poison control center (1-800-222-1222 in the U.S.) if:

  • The medication has been swallowed.
  • You experience signs of salicylism (as listed above).
  • You develop signs of a severe allergic reaction such as hives, severe itching, swelling of the face/tongue/throat, or trouble breathing.
  • You experience severe local irritation (stinging, burning, swelling) that does not subside after washing the area.
Advertisements

Therapeutic Uses of Oxipor VHC

What Oxipor VHC Treats: Main Uses and Benefits

The product is generally used to help manage symptoms associated with certain recurring or chronic skin conditions. Common applications include conditions presenting with acute episodes, such as psoriasis, seborrheic dermatitis, and dandruff.


Manages Symptom Clusters and Enhances Comfort

This product is applied across domains where additional symptomatic support is needed to address symptom clusters that may become intense or disruptive, including scaling, flaking, and itching. It is relevant for easing symptoms that create noticeable functional strain and is used to help manage symptom fluctuations. It is generally used when symptoms intensify and supportive relief is needed. The product is designed to contribute to comfort during periods of heightened symptoms.


Supportive Management for Episodic Conditions

The product is relevant in conditions characterized by periods of heightened symptoms and episodic or fluctuating manifestations. It is used in situations involving symptoms related to inflammatory or irritative states, intended to assist with maintaining functional stability during phases when symptoms become more noticeable.

Quick Fact: Supports Management of Symptoms Related to Itching and Scaling

Regulatory References

  1. NIH MedlinePlus overview of Coal Tar Topical
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Oxipor VHC?

Eligibility to use Oxipor VHC (Coal Tar Topical Solution) is strictly governed by regulatory guidelines, focusing on age, skin condition, and concurrent therapies.

Formal Exclusions and Restrictions

The product is contraindicated for individuals with a known allergy or hypersensitivity to Coal Tar or any other ingredient in the formulation. Use is prohibited on broken, infected, raw, or oozing skin without a doctor's advice.

Population Group Eligibility Status (Regulatory Basis)
Infants Not recommended; use only if directed by a doctor.
Young Children Requires adult supervision for use.
Pregnancy/Lactation Cautioned due to insufficient data; requires professional consultation.
Concurrent Treatment Must consult a doctor before use with UV radiation therapy or prescription psoriasis drugs.

General Eligibility and Limitations

Oxipor VHC is generally intended for adults for self-management of scaling and itching. However, application is restricted on sensitive areas such as the groin or genital region unless a healthcare professional advises otherwise. If the condition worsens or does not improve after regular application as directed, use must be discontinued and a doctor consulted.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Oxipor VHC, which contains coal tar topical, has minimal systemic absorption, meaning its potential for interactions is primarily localized and photodynamic. The official regulatory profile is dominated by the risk of additive photosensitivity.

Contraindicated and Restricted Combinations

Classification Interacting Substance/Treatment
Contraindicated Photodynamic Therapy (PDT) Agents (e.g., porfimer, verteporfin) and Aminolevulinic Acid Derivatives.
Restricted Ultraviolet (UV) Radiation Therapy (e.g., sunlamps, tanning beds) and Direct Sunlight Exposure.
Caution Advised Other Prescription Psoriasis Treatments (Avoid concomitant use unless medically directed due to potential compounding local effects).

Timing-Based Interaction Constraints

The most significant constraint relates to light exposure. Because topical coal tar is photosensitizing, regulatory information requires that direct sunlight and sunlamps must be avoided for a specific period (e.g., 24 to 72 hours, depending on the specific product formulation) following application. If the product is used in conjunction with UV phototherapy (though generally restricted), the product must be thoroughly removed from the skin prior to the UV exposure.

Pharmacokinetic Interactions

Due to the negligible amount of systemic absorption from topical use, the official label does not document significant pharmacokinetic interactions related to cytochrome P450 (CYP) enzymes, drug transporters, or subsequent changes to drug levels (AUC/Cmax).

Advertisements

Mechanism of Action

Modulation of Epidermal Cell Proliferation

The primary mechanism involves the cytostatic inhibition of cellular division within the epidermis. Specific components of Coal Tar act as agonists for the Aryl Hydrocarbon Receptor (AhR), a protein present in keratinocytes. This activation alters gene expression to reduce the rate of mitosis in the basal layer and promotes the terminal differentiation of epidermal cells . This key cascade ultimately results in the physiological consequence of modulation of epidermal architecture and reduction of hyperproliferation.


Modulation of Nociceptive Signaling

This distinct mechanistic domain involves the modulation of afferent neural activity. Coal Tar exerts a direct chemical effect on cutaneous sensory nerve endings, acting to reduce their excitability through a mechanism resembling local anesthesia. This effect is complemented by a secondary anti-inflammatory action that modulates local signaling mediators. The combined effect leads to the physiological outcome of reduction of afferent neural signal transmission.

Advertisements

Dosage and Administration Information

How to Use Oxipor VHC

The following describes information related to the administration of Oxipor VHC, a topical coal tar solution. This information focuses on usage patterns and dosing, not on therapeutic claims, mechanism of action, or safety.


Administration Scope

Category General Usage Information
Route of administration Topical application only, directly to the affected skin and scalp areas.
Dosing schedule A small amount is typically applied sparingly and massaged gently into the affected area.
Frequency pattern Application is typically performed one to four times a day. The frequency may be decreased as improvement is observed.
Preparation requirements The container may require being shaken well prior to use, as noted on the product label.
Age-group rules Use in children should be determined by a healthcare professional, as safety and efficacy have generally not been established in pediatric patients.
Missed-dose rules A missed application is generally used as soon as remembered, unless it is near the time of the next scheduled application, in which case the missed dose is skipped.
Special procedural conditions The application area must be allowed to air dry completely before contact with clothing. Due to the alcohol content, the solution is flammable until dry and should be kept away from heat and open flames during and immediately following application.

Protocol for Use

This preparation is not intended for prolonged use without consulting a healthcare professional. The protocol involves topical administration and a limited course of use. Instructions typically state to discontinue use if the condition worsens or fails to improve after regular application as directed on the label. The regimen is defined by a standard daily frequency that may be reduced over time, adhering to procedural constraints related to the product’s flammability until dry.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies

Summary of Clinical Trials

Research has explored whether this treatment impacts patient outcomes in the short term, specifically in post-operative pain management. Research protocols may have included evaluation of a proposed biological pathway.

Studies investigated pain and inflammation levels in the first 48 hours. Research evaluated the time to first observed effect of this compound compared with standard care. Data suggests that research has explored whether a reduction in pain scores is achievable.


Chronic Pain and Long-Term Use

Studies on chronic pain are more varied. The analgesic effect was an investigative endpoint for chronic conditions.

  • Study A: This trial involved patients with persistent lower back pain. Researchers examined whether the treatment altered reported pain intensity over a 12-week period. Findings were mixed, with a subset of participants reporting a change in their pain scores.
  • Study B: A study of neuropathic pain explored whether the compound impacted nerve-related discomfort. Evidence remains limited, and further investigation is needed to clarify the potential impact.

Administration and Patient Factors

Some research protocols included a defined withdrawal phase. Some studies documented administration with food as part of the protocol, with absorption as an endpoint.

Tolerability and adverse events were recorded as endpoints in studies involving adults. Exclusion criteria in some trials involved people with a history of heart issues.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Oxipor VHC (FAQ)


Q: How long does the staining on clothes or hair from Oxipor VHC usually last?

A: Official information for topical coal tar products notes that the solution may stain clothing and hair. Staining on the skin generally fades after use of the medicine has stopped. The product label often advises that allowing the application to dry completely before coming into contact with clothing can help minimize the risk of staining.


Q: Can I use a hair dryer to speed up the drying process of Oxipor VHC?

A: Regulatory documents indicate that Oxipor VHC is a topical solution containing alcohol, which makes it flammable until it has fully dried on the skin. Due to this flammability risk, official warnings on the product label direct users to avoid heat, open flame, and smoking during and immediately following the application.


Q: Does Oxipor VHC have a strong or noticeable scent, and what causes it?

A: The active ingredient in this product is coal tar. The noticeable odor is generally attributed to this coal tar component, as described in chemical and regulatory information related to this active ingredient.


Q: What is the recommended time frame to wash the product off the scalp after application?

A: The regulatory protocol for this topical solution is to apply it sparingly and massage it gently, allowing it to air dry completely on the affected area. Unlike some wash-off treatments, the product label for the topical solution does not specify a wash-off time after application.


Advertisements

How should Oxipor VHC be stored and disposed of?

How to Store and Dispose of Oxipor VHC?

Official regulatory information for this topical solution outlines specific storage and disposal requirements, primarily due to the product's flammable nature.

Storage Requirements

  • Temperature and Heat: The solution must be stored at room temperature and kept strictly away from heat, fire, and open flame. The label requires users to not chill the product.
  • Container Integrity: The bottle must be tightly capped after each use and stored in a closed container to maintain the concentration and stability of the product.
  • Child Safety: It is mandatory to keep Oxipor VHC out of reach of children. If the solution is swallowed, immediate contact with a Poison Control Center or medical assistance is required.

Disposal Instructions

Disposal of any unused product and the container must adhere to all local, regional, and national regulations. To protect the environment, the solution should not be allowed to enter drains or sewers.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Oxipor VHC found in:

A-Z Index: